Clinical Trial Packaging
Full-service clinical supply packaging for Phase I through Phase IV studies - including patient-specific kitting, randomization, blinding, comparator sourcing, and multi-country labeling for global trial programs.
OVERVIEW
Clinical trial packaging operates at the intersection of pharmaceutical manufacturing, regulatory compliance, and clinical operations. Every kit, label, and shipment must meet the specific requirements of the study protocol, the applicable regulatory framework - including GMP Annex 13 for investigational medicinal products - and the operational needs of clinical sites and patients across multiple countries and languages. Meridan provides the clinical supply packaging expertise and infrastructure to support these complex programs from first-patient-in through study completion.
Our clinical packaging operations serve sponsors and contract research organizations across all study phases, from early-phase studies requiring small, highly customized patient kits to large-scale Phase III and Phase IV programs involving thousands of patients across dozens of countries. We maintain dedicated clinical packaging suites within our FDA-registered facilities, staffed by experienced clinical packaging specialists who understand the unique demands of investigational product handling, blinding integrity, and protocol-driven packaging requirements.
STUDY PHASES
All Phases, All Complexities
First-in-human studies with small patient populations. Highly customized kitting, flexible dosage configurations, and rapid turnaround.
Dose-finding and efficacy studies. Randomized, blinded packaging with multiple dose strengths and placebo configurations.
Pivotal registration studies with large patient populations across multiple countries. Scale-up of blinded packaging with full regulatory labeling.
Post-approval and lifecycle management studies. Commercial-scale clinical packaging with extended stability and market-specific labeling.
KITTING
Patient-Specific Kitting
Patient-specific kitting is the core of clinical trial packaging, assembling the exact combination of investigational product, comparator, placebo, ancillary supplies, and patient materials required by each study protocol. Our kitting operations support a wide range of configurations from simple single-product kits to complex multi-visit, multi-component kits that include multiple dosage forms, titration schedules, and rescue medications.
Each kit is assembled following documented work instructions derived from the study protocol and randomization scheme. Barcode scanning at every assembly step verifies that the correct components, lot numbers, and kit numbers are matched according to the randomization list. Weight verification and photographic documentation provide additional quality checks before kits are sealed and released. Our kitting operations support both inventory-based (pre-built) and demand-based (just-in-time) models depending on the study design and enrollment pace.
- ✓Single and multi-component kit configurations
- ✓Barcode-verified component assembly
- ✓Inventory-based and demand-based kitting models
- ✓Photographic documentation and weight verification
BLINDING
Randomization & Blinding
Maintaining blinding integrity is essential to the scientific validity of clinical trials. Meridan provides comprehensive blinding services including over-encapsulation of tablets and capsules, matching placebo manufacturing coordination, identical packaging and labeling of active and placebo products, and blinding assessment documentation that demonstrates the visual and tactile indistinguishability of blinded treatments.
Our randomization packaging processes are designed to prevent any possibility of unblinding during the packaging, labeling, or distribution process. Segregated work areas, controlled access to randomization lists, and two-person verification procedures ensure that blinding integrity is maintained from the point of packaging through delivery to the clinical site. We support both simple randomization and complex adaptive randomization designs, working directly with sponsors and their interactive response technology systems to execute the randomization scheme accurately.
- ✓Over-encapsulation and matching placebo coordination
- ✓Identical active and placebo packaging
- ✓Blinding assessment and documentation
- ✓Simple and adaptive randomization support
SOURCING
Comparator Sourcing
Many clinical trials require comparator products - marketed drugs against which the investigational product is compared. Sourcing comparators involves navigating complex pharmaceutical supply chains to procure authentic, properly documented product from authorized channels while maintaining full traceability and documentation compliance. Meridan's comparator sourcing services manage this process, securing comparator products from authorized distributors in the required market presentations and quantities.
Our sourcing team coordinates procurement, importation, and receipt of comparator products with complete chain-of-custody documentation. We verify product identity, lot numbers, expiration dates, and packaging integrity upon receipt, and manage comparator inventory within our temperature-controlled storage facilities. For blinded studies, we coordinate comparator modification including over-encapsulation, re-packaging, and re-labeling to match the investigational product presentation while maintaining full product traceability.
- ✓Procurement from authorized distribution channels
- ✓Full chain-of-custody documentation
- ✓Over-encapsulation and blinding modification
- ✓Temperature-controlled comparator storage
LABELING
Multi-Country Labeling
Global clinical trials require investigational product labeling that complies with the regulatory requirements of every participating country. Meridan's clinical labeling capabilities support multi-language, multi-country labeling programs that meet the specific requirements of each regulatory authority, including EU GMP Annex 13, FDA 21 CFR Part 312, Health Canada, and ICH guidelines for investigational product labeling.
Our labeling team manages the complexity of multi-country clinical label content, coordinating country-specific text requirements, language translations, and local regulatory references across all label formats. We support booklet labels that accommodate multiple languages on a single primary container, peel-back labels for small containers, and country-specific carton labeling. Each label version undergoes documented proofreading and quality review against approved label text before production. Label reconciliation processes ensure complete accountability for all printed labels throughout the production and packaging process.
- ✓Regulatory-compliant labeling for global markets
- ✓Multi-language booklet and peel-back label formats
- ✓Documented proofreading and quality review
- ✓GMP Annex 13 and ICH-compliant label content
INTEGRATION
IRT Integration
Interactive Response Technology systems - including both interactive voice response and interactive web response platforms - are the central control systems for clinical supply management in modern clinical trials. Meridan integrates directly with all major IRT platforms to receive real-time packaging and distribution instructions, report inventory levels, confirm shipments, and update supply status throughout the study lifecycle.
Our IRT integration capabilities support automated depot management workflows where the IRT system drives packaging orders, inventory replenishment triggers, site shipment instructions, and return/destruction processing. We maintain established technical connections with the industry's most widely used IRT platforms and can configure new integrations to support custom workflows required by specific study designs. Our clinical operations team works alongside the sponsor's supply chain managers to ensure the IRT configuration aligns with the packaging and distribution plan for each study.
- ✓Integration with all major IRT platforms
- ✓Automated packaging orders and shipment instructions
- ✓Real-time inventory reporting and replenishment
- ✓Returns management and destruction processing
INFRASTRUCTURE
Clinical Operations Infrastructure
Our clinical trial packaging operations are supported by dedicated facilities, trained personnel, and specialized systems designed for the unique requirements of investigational products. Every aspect of our clinical infrastructure is maintained within a quality system that meets both FDA and EU GMP requirements for clinical trial materials.
Clinical Capabilities
Packaging & Labeling
- Dedicated Clinical Suites
Segregated packaging areas for investigational products - Clinical Label Printing
On-demand digital label printing with variable data - Blinding Operations
Over-encapsulation, matching, and blinding assessment
Supply Chain
- IRT Connectivity
Automated integration with major IRT platforms - Global Distribution
Qualified courier networks for direct-to-site shipping - Returns & Destruction
Documented reconciliation and compliant destruction
Regulatory Compliance
- •FDA 21 CFR Part 211 and Part 312
- •EU GMP Annex 13 (Investigational Medicinal Products)
- •ICH GCP (Good Clinical Practice)
- •Health Canada Division 5 compliance
- •DEA licensed for controlled substance trials
- •Cold chain qualified for 2-8\u00B0C, -20\u00B0C, and -80\u00B0C
Related Resources
View Case Study: Global Phase III Clinical SupplyReady to optimize your packaging operations?
Partner with Meridan for reliable, compliant pharmaceutical packaging at scale.